Andres Yarur

20PUBLICATIONS
43CO-AUTHORS
Proteins and peptidesRecordkeeping informaticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 12, 2026
Beyond calprotectin: where leucine-rich α2-glycoprotein may fit in small bowel Crohn disease monitoring.

|Jul 03, 2026
Performance of Google NotebookLM for AI-assisted data extraction and consensus statement generation in a heterogenous systematic review on inflammatory bowel disease, obesity, and cardiometabolic comorbidities: A Methodological Report.

|Apr 15, 2026
Impact of Immunogenicity on Clinical Outcomes in Patients With Moderate-to-Severe Inflammatory Bowel Disease Receiving Subcutaneous Infliximab: A Post Hoc Analysis of the LIBERTY Trials.

|Mar 18, 2026
Recovery of response and long-term outcomes following loss of response and dose escalation of subcutaneous infliximab: a post hoc analysis of the LIBERTY-CD & LIBERTY-UC trials.

Marla C Dubinsky, Stefan Schreiber, Andres J Yarur

|Sep 26, 2025
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid.

Andres Yarur, Peter Irving, Britta Siegmund

|Mar 04, 2025
Efficacy and Safety of Etrasimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Baseline Modified Mayo Score: A Post Hoc Analysis From the Phase 3 ELEVATE UC Clinical Program.

Bruce E Sands, Marla C Dubinsky, Paulo G Kotze

Pageof 4

Frequent Collaborators

3 joint publications

Bruce E Sands

2 joint publications

Young Nam Lee

2 joint publications

Silvio Danese

2 joint publications

Parakkal Deepak